HSG Holding’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
152,299
-1
| -0% | -$9 | 0.07% | 16 |
|
|
2025
Q1 | $1.46M | Hold |
152,300
| – | – | 0.09% | 14 |
|
|
2024
Q4 | $1.74M | Hold |
152,300
| – | – | 0.07% | 15 |
|
|
2024
Q3 | $3.41M | Hold |
152,300
| – | – | 0.13% | 14 |
|
|
2024
Q2 | $5M | Hold |
152,300
| – | – | 0.18% | 12 |
|
|
2024
Q1 | $7.43M | Hold |
152,300
| – | – | 0.69% | 11 |
|
|
2023
Q4 | $6.4M | Hold |
152,300
| – | – | 0.74% | 11 |
|
|
2023
Q3 | $4.48M | Hold |
152,300
| – | – | 0.48% | 15 |
|
|
2023
Q2 | $9.69M | Hold |
152,300
| – | – | 1.11% | 13 |
|
|
2023
Q1 | $7.19M | Hold |
152,300
| – | – | 0.76% | 11 |
|
|
2022
Q4 | $10.6M | Hold |
152,300
| – | – | 1.07% | 11 |
|
|
2022
Q3 | $22.3M | Hold |
152,300
| – | – | 2.4% | 10 |
|
|
2022
Q2 | $19.9M | Hold |
152,300
| – | – | 1.83% | 12 |
|
|
2022
Q1 | $15.4M | Hold |
152,300
| – | – | 1.92% | 13 |
|
|
2021
Q4 | $23.6M | Hold |
152,300
| – | – | 2.11% | 12 |
|
|
2021
Q3 | $45.1M | Buy |
152,300
+30,460
| +25% | +$9.02M | 4.05% | 10 |
|
|
2021
Q2 | $39.6M | Buy |
+121,840
| New | +$39.6M | 2.76% | 8 |
|